Akiram Therapeutics AB
Pioneering targeted radioimmunotherapy to treat incurable solid tumors effectively.
Overview
- Unknown
- Employees
- Unknown
- Revenue
- 2021
- Founded
Key Decision Makers
Marika Nestor
Chief Executive Officer, Co-Founder
Anna Törner
Board member
Peder Walberg
Board Member
Peter Frank
Head of CMC Chemistry, Manufacturing and Control
+4 more contacts in Funnelfeedr
Description
Akiram Therapeutics is an emerging Swedish biotechnology company dedicated to revolutionizing cancer treatment. They specialize in developing innovative, targeted radioimmunotherapy designed to treat solid tumors, particularly metastatic cancers. Their proprietary approach combines radioactive molec...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Tillverkning av läkemedel
- Legal Form
- Aktiebolag
- VAT Number
- SE559338745801
Decision Makers
8 contacts in FunnelfeedrMarika Nestor
Chief Executive Officer, Co-Founder
Anna Törner
Board member
Peder Walberg
Board Member
Peter Frank
Head of CMC Chemistry, Manufacturing and Control
Fredrik Frejd
Chief Strategy Officer, Co-founder
Anja Mortensen
Chief Technology Officer, Co-founder
Tina Furebring
Project management / operations Drug discovery and clinical translation
Other Contacts
Jan Zedenius
Clinical advisor
Similar Companies
20 similar companies in Funnelfeedr
Acrivon AB
10–19 employeesDeveloping targeted cancer therapies using proprietary proteomics platform.
SACRA Therapeutics AB
0 employeesSACRA pioneers novel RNA-targeting therapies for incurable cancers.
Affibody AB
50–99 employeesDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
AAX Biotech AB
5–9 employeesResearch-driven biotech advancing antibody therapies via proprietary technology.
CANTARGIA AB
20–49 employeesDeveloping antibody-based drugs targeting IL1RAP for serious diseases.
Akiram Therapeutics AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo